Wird geladen...

Miliary Tuberculosis in a Crohn's Disease Patient: The Risk beyond the Screening

Tumor necrosis factor alpha (TNFα) antagonist is recognized as an effective treatment to achieve clinical remission and healing mucosal in patients with moderate to severe active Crohn's disease. Considering that it plays a central role in immune-mediated modulation, there are some obvious conc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:GE Port J Gastroenterol
Hauptverfasser: Carvalho, Liliana Pereira, Túlio, Maria Ana, Rodrigues, José Pedro, Bana e Costa, Tiago, Chagas, Cristina
Format: Artigo
Sprache:Inglês
Veröffentlicht: S. Karger AG 2018
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6341350/
https://ncbi.nlm.nih.gov/pubmed/30675506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487297
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!